chr3-142499702-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001184.4(ATR):c.5305G>C(p.Glu1769Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000131 in 152,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001184.4 missense
Scores
Clinical Significance
Conservation
Publications
- Seckel syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, G2P, Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndromeInheritance: Unknown, AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- Seckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial prostate carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152192Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.00000398  AC: 1AN: 251456 AF XY:  0.00   show subpopulations 
GnomAD4 exome Cov.: 30 
GnomAD4 genome  0.0000131  AC: 2AN: 152192Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 74348 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
- -
Inborn genetic diseases    Uncertain:1 
The p.E1769Q variant (also known as c.5305G>C), located in coding exon 31 of the ATR gene, results from a G to C substitution at nucleotide position 5305. The glutamic acid at codon 1769 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome    Uncertain:1 
- -
Seckel syndrome 1    Uncertain:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at